MedTrace Logo

Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain

NCT05125978 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2023-09-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Canadá association in the treatment of chronic pain

Conditions

  • Pain, Chronic

Interventions

DRUG

Canadá

Canadá association 1 tablet twice a day

OTHER

Canadá placebo

Placebo of Canadá association 1 tablet twice a day

DRUG

Dipyrone

Dipyrone 1 tablet twice a day

OTHER

Dipyrone placebo

Placebo of dipyrone 1 tablet twice a day

DRUG

Tramadol hydrochloride

Tramadol 1 coated tablet twice a day

OTHER

Tramadol hydrochloride placebo

Placebo of tramadol 1 coated tablet twice a day

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2028-07-31
Completion
2028-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05125978 on ClinicalTrials.gov